Menu

Alan Rabson, Former Deputy Director of the NCI, Dies

Rabson’s career at the National Cancer Institute spanned six decades.

Jul 6, 2018
Sukanya Charuchandra
Alan Rabson
NCI

Alan Rabson, whose research career at the National Cancer Institute lasted six decades and culminated with his role as deputy director for 20 years, died on July 4. He was 92.

“We have lost a giant,” says Norman Sharpless, the director of the NCI, in a statement.

Born and raised in New York City, Rabson obtained a medical degree from the State University of New York. He started his career at the NCI in 1955 after a failed attempt at acquiring an internship at the organization in 1947 and a lack of opportunities in the early 1950s.. According to the NCI’s oral history project, Rabson spent his first year at the NCI as a resident in the pathology department with only a desk and a microscope for his laboratory. In the following year, he was given a fully functioning lab and a technician.

Rabson studied tumor-causing viruses, working extensively as a pathologist, virologist, and clinical researcher. Rabson was known for his dedication to clinical care, helping many cancer patients find the right treatment and clinical trial. Since 2012, the Alan S. Rabson Award for Clinical Care has been given to individuals likeminded for their efforts to help NIH patients.

In 1975, he was named the director of the precursor to the NCI’s cancer biology division, and from 1995 to his retirement in 2015, Rabson was the deputy director of the NCI.

“He had an inimitable leadership style,” Doug Lowy, the current deputy director of NCI, says in the statement. “When you talked with him, he spent most of the time trying to understand what you needed, so he could help you, rather than spending it figuring out how you could help him. He truly believed that if you were successful, he was successful.”

Along with his wife Ruth Kirschstein, a scientist who passed away in 2009, Rabson was a prominent leader within the NIH community. Additionally, he was a professor at George Washington University and Georgetown University. After hearing of Rabson’s death, Francis Collins, the NIH director, tweeted about his colleague, “Al always went the extra mile.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.